BCD-132
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BCD-132, covering 2024-11-25 to 2025-05-23. Get the full timeline:
Most recent: Clinical Trial Update: An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Previously Received Therapy in Clinical Studies of JSC BIOCAD [Phase 3]